Recursion Pharmaceuticals
RXRX
#5297
Rank
HK$11.97 B
Marketcap
HK$19.21
Share price
-9.93%
Change (1 day)
-40.82%
Change (1 year)

EPS for Recursion Pharmaceuticals (RXRX)

EPS in 2026 (TTM): -HK$7.05

According to Recursion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$7.06. In 2025 the company made an earnings per share (EPS) of -HK$11.60 an increase over its 2024 EPS that were of -HK$13.01.

EPS history for Recursion Pharmaceuticals from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$7.05-39.27%
2025-HK$11.60-10.84%
2024-HK$13.015.73%
2023-HK$12.3114.6%
2022-HK$10.7417.39%
2021-HK$9.15